上海药明生物技术有限公司 Wuxi Biologics
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
WuXi Biologics Selected into the Hang Seng HK 35 Index 2018-08-30 10:08
WuXi Biologics Reports Robust 2018 Interim Results 2018-08-20 20:25
WuXi Biologics Commenced Process Validation in MFG2 2018-07-31 07:55
WuXi Biologics Announced Successful Completion of the First cGMP Run in MFG3 2018-07-25 07:55
WuXi Biologics and Immune Pharmaceuticals Announce Late-Phase Development and Manufacturing Partnership for a First-In-Class Monoclonal Antibody 2018-07-09 22:00
WuXi Biologics and Harbour BioMed Announce Strategic Development and Manufacturing Partnership 2018-06-25 07:55
WuXi Biologics Initiated Construction of a State-of-the-Art Integrated ADC Solution Center 2018-06-20 08:03
WuXi Biologics to Invest $60 Million to Establish a Biologics Production Facility in the United States 2018-06-11 08:34
WuXi Biologics and Tsinghua University Innovation Center for Immune Therapy Sign MOU and Announce Strategic Partnership 2018-05-30 08:34
WuXi Biologics to Invest S$80 Million to Establish a Biologics Manufacturing Facility in Singapore 2018-05-22 18:34
WuXi Biologics and Bioasis Announce Initial Strategic Collaboration for the Development and Manufacturing of Bioasis' Lead Investigational Candidate to Treat Brain Cancer 2018-05-21 20:30
WuXi Biologics to Build an Integrated Biologics Development, Clinical and Commercial Manufacturing Center in Shijiazhuang 2018-05-16 18:09
WuXi Biologics to Invest €325 Million to Build Largest Biomanufacturing Facility Using Single-Use Bioreactors in Ireland 2018-04-30 20:41
WuXi Biologics Wins CMO Leadership Award from Life Science Leader Magazine 2018-04-17 08:13
WuXi Biologics to Install Industry's Largest Single-Use Bioreactor from ABEC at its New Commercial Manufacturing Facility 2018-03-21 08:18
WuXi Biologics Reports Remarkable 2017 Annual Results: Revenue up 63.7% to a Record High of RMB1,618.8 Million 2018-03-19 20:41
WuXi Biologics and Adagene Announce Strategic Development and Manufacturing Partnership 2018-03-09 11:43
WuXi Biologics Congratulates TaiMed on FDA Approval for Trogarzo 2018-03-07 12:24
WuXi Biologics Receives Asia's CMO of 2017 from BioPharma Industry Awards 2018-03-06 14:11
WuXi Biologics Announces Positive Profit Alert 2018-03-05 17:48
1 5 6 7 8 9